

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.53464727 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.47079034 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.47079034 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.47079034 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.47079034 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.47079034 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.47079034 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.92440262 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.84221258 |
| 10 | detection of other organism (GO:0098543) | 4.62217807 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.46891530 |
| 12 | detection of external biotic stimulus (GO:0098581) | 4.27041688 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.26414859 |
| 14 | detection of bacterium (GO:0016045) | 4.23419993 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.18140494 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.10328929 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.10328929 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.07734634 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.03091742 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.92620408 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.92620408 |
| 22 | positive regulation of B cell differentiation (GO:0045579) | 3.88675111 |
| 23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.82384452 |
| 24 | detection of biotic stimulus (GO:0009595) | 3.73596717 |
| 25 | response to host immune response (GO:0052572) | 3.62699320 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.62699320 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 3.54304224 |
| 28 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.49785499 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.48786312 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45589274 |
| 31 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.44382921 |
| 32 | B cell receptor signaling pathway (GO:0050853) | 3.44329066 |
| 33 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.40203471 |
| 34 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.38690460 |
| 35 | response to host (GO:0075136) | 3.38690460 |
| 36 | response to host defenses (GO:0052200) | 3.38690460 |
| 37 | microglial cell activation (GO:0001774) | 3.35354394 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.32647580 |
| 39 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.32450771 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.30750179 |
| 41 | negative regulation of granulocyte differentiation (GO:0030853) | 3.29371297 |
| 42 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.24694943 |
| 43 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.24537463 |
| 44 | positive regulation of antigen processing and presentation (GO:0002579) | 3.24282675 |
| 45 | positive regulation of mast cell degranulation (GO:0043306) | 3.19272726 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.19272726 |
| 47 | glycosphingolipid catabolic process (GO:0046479) | 3.18820314 |
| 48 | positive regulation of interferon-beta production (GO:0032728) | 3.17883951 |
| 49 | response to peptidoglycan (GO:0032494) | 3.17820297 |
| 50 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.16386402 |
| 51 | I-kappaB phosphorylation (GO:0007252) | 3.15835476 |
| 52 | mannose metabolic process (GO:0006013) | 3.12507467 |
| 53 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.08646477 |
| 54 | positive regulation of leukocyte degranulation (GO:0043302) | 3.07528864 |
| 55 | amino sugar catabolic process (GO:0046348) | 3.07209564 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.05030085 |
| 57 | pinocytosis (GO:0006907) | 3.04672984 |
| 58 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.04335558 |
| 59 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.02078987 |
| 60 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.00317118 |
| 61 | respiratory burst (GO:0045730) | 3.00034385 |
| 62 | neutrophil activation (GO:0042119) | 2.98481346 |
| 63 | macrophage activation (GO:0042116) | 2.98189177 |
| 64 | negative regulation of interleukin-12 production (GO:0032695) | 2.97909449 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97049725 |
| 66 | response to muramyl dipeptide (GO:0032495) | 2.96040150 |
| 67 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.93961002 |
| 68 | negative regulation of T cell mediated immunity (GO:0002710) | 2.89634257 |
| 69 | protein localization to endosome (GO:0036010) | 2.88775426 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86107434 |
| 71 | apoptotic cell clearance (GO:0043277) | 2.84819671 |
| 72 | regulation of macrophage cytokine production (GO:0010935) | 2.84805115 |
| 73 | glycolipid catabolic process (GO:0019377) | 2.84448172 |
| 74 | granulocyte activation (GO:0036230) | 2.83877121 |
| 75 | T-helper 1 type immune response (GO:0042088) | 2.82879313 |
| 76 | regulation of tolerance induction (GO:0002643) | 2.81597242 |
| 77 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.80941526 |
| 78 | positive regulation of macrophage cytokine production (GO:0060907) | 2.80494114 |
| 79 | response to type I interferon (GO:0034340) | 2.78396125 |
| 80 | regulation of T cell tolerance induction (GO:0002664) | 2.78272171 |
| 81 | oligosaccharide catabolic process (GO:0009313) | 2.78077020 |
| 82 | positive thymic T cell selection (GO:0045059) | 2.77502374 |
| 83 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.77326684 |
| 84 | regulation of cholesterol storage (GO:0010885) | 2.77226305 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76184258 |
| 86 | regulation of regulated secretory pathway (GO:1903305) | 2.75990534 |
| 87 | B cell mediated immunity (GO:0019724) | 2.75826384 |
| 88 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.75061296 |
| 89 | negative regulation of interleukin-17 production (GO:0032700) | 2.71998089 |
| 90 | cellular extravasation (GO:0045123) | 2.71868838 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 2.71553354 |
| 92 | type I interferon signaling pathway (GO:0060337) | 2.71544048 |
| 93 | cellular response to type I interferon (GO:0071357) | 2.71544048 |
| 94 | germinal center formation (GO:0002467) | 2.68656044 |
| 95 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.66013836 |
| 96 | NIK/NF-kappaB signaling (GO:0038061) | 2.64935921 |
| 97 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.64260055 |
| 98 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.63187485 |
| 99 | neutrophil mediated immunity (GO:0002446) | 2.61428910 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.61241534 |
| 101 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.59933967 |
| 102 | B cell homeostasis (GO:0001782) | 2.57474877 |
| 103 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.55965535 |
| 104 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55949493 |
| 105 | regulation of integrin activation (GO:0033623) | 2.54333142 |
| 106 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.54121453 |
| 107 | negative thymic T cell selection (GO:0045060) | 2.53951246 |
| 108 | leukocyte aggregation (GO:0070486) | 2.51901266 |
| 109 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51007809 |
| 110 | regulation of interferon-beta production (GO:0032648) | 2.50824668 |
| 111 | cellular response to exogenous dsRNA (GO:0071360) | 2.50551335 |
| 112 | regulation of phagocytosis (GO:0050764) | 2.50404563 |
| 113 | detection of molecule of bacterial origin (GO:0032490) | 2.50401870 |
| 114 | negative regulation of lipid storage (GO:0010888) | 2.48219527 |
| 115 | response to laminar fluid shear stress (GO:0034616) | 2.48180437 |
| 116 | leukocyte cell-cell adhesion (GO:0007159) | 2.48084324 |
| 117 | regulation of mast cell activation (GO:0033003) | 2.47580450 |
| 118 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.47482546 |
| 119 | regulation of mast cell degranulation (GO:0043304) | 2.46985628 |
| 120 | negative T cell selection (GO:0043383) | 2.45715315 |
| 121 | mature B cell differentiation (GO:0002335) | 2.43193823 |
| 122 | defense response to protozoan (GO:0042832) | 2.42239505 |
| 123 | positive regulation of phagocytosis (GO:0050766) | 2.41386615 |
| 124 | phospholipid homeostasis (GO:0055091) | 2.40602514 |
| 125 | negative regulation of bone resorption (GO:0045779) | 2.38867928 |
| 126 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.37745716 |
| 127 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.36917267 |
| 128 | natural killer cell mediated immunity (GO:0002228) | 2.36917267 |
| 129 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.36722418 |
| 130 | myeloid leukocyte activation (GO:0002274) | 2.36039125 |
| 131 | tolerance induction (GO:0002507) | 2.35715904 |
| 132 | negative regulation of interleukin-6 production (GO:0032715) | 2.35295411 |
| 133 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.32693809 |
| 134 | positive regulation of mast cell activation (GO:0033005) | 2.30271684 |
| 135 | regulation of leukocyte degranulation (GO:0043300) | 2.28856475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.91853073 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.41054094 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.73970686 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.69034781 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.60223647 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.58883198 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.51735299 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25898979 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15167689 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.03293090 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.98653956 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.76904573 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75499731 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.73041167 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.70802477 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.70740076 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.61255625 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.35336429 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34911042 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.33428833 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.33212972 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31474682 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.28496131 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.28048490 |
| 25 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.19414259 |
| 26 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.19142348 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17816468 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.98609490 |
| 29 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.96793036 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96432252 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.95910907 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.93288485 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93284445 |
| 34 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.90352302 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89333423 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.88797545 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87696936 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87589321 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87541394 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87214517 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83193338 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81708552 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.75224466 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.72638154 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70657217 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69207120 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.62909350 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56392664 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54342609 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54305764 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53093452 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46969273 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46110143 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44786445 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44503892 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36696444 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35635112 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35344281 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33677370 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33514165 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33409624 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31872616 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31206291 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30059964 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26029464 |
| 66 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25742383 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23601406 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22249479 |
| 69 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20822645 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20333684 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20068032 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19809329 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18009034 |
| 74 | GATA2_19941826_ChIP-Seq_K562_Human | 1.17442634 |
| 75 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14728275 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11308150 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10990559 |
| 78 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10239139 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09812957 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09480483 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07806216 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06283719 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06096157 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04320192 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 1.03169997 |
| 86 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01115355 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99909838 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99806081 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98470715 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95575503 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.95364373 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95321486 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93995127 |
| 94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93828868 |
| 95 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93781124 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93096482 |
| 97 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91998717 |
| 98 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91594700 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91058520 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90697779 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90277081 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89496463 |
| 103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89406214 |
| 104 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88768279 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87693011 |
| 106 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87080162 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85560352 |
| 108 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84383631 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84296703 |
| 110 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83865055 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83717207 |
| 112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83250036 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82983005 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79981636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.65435707 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.64225053 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.19923537 |
| 4 | MP0003436_decreased_susceptibility_to | 2.90775915 |
| 5 | MP0003303_peritoneal_inflammation | 2.71151686 |
| 6 | MP0002419_abnormal_innate_immunity | 2.58467551 |
| 7 | MP0005464_abnormal_platelet_physiology | 2.54184758 |
| 8 | MP0001800_abnormal_humoral_immune | 2.54094871 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.51134028 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.49145942 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.47905094 |
| 12 | MP0001790_abnormal_immune_system | 2.46654514 |
| 13 | MP0005387_immune_system_phenotype | 2.46654514 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.42791580 |
| 15 | MP0000685_abnormal_immune_system | 2.39276905 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.37774365 |
| 17 | MP0008260_abnormal_autophagy | 2.33303579 |
| 18 | MP0005671_abnormal_response_to | 2.31408157 |
| 19 | MP0005025_abnormal_response_to | 2.27514198 |
| 20 | MP0002723_abnormal_immune_serum | 2.17518133 |
| 21 | MP0006082_CNS_inflammation | 2.16578585 |
| 22 | MP0009785_altered_susceptibility_to | 2.09329717 |
| 23 | MP0009840_abnormal_foam_cell | 2.05155685 |
| 24 | MP0005451_abnormal_body_composition | 2.01588402 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.00808968 |
| 26 | MP0003828_pulmonary_edema | 2.00761078 |
| 27 | MP0001819_abnormal_immune_cell | 2.00518014 |
| 28 | MP0004947_skin_inflammation | 1.88927902 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.88819670 |
| 30 | MP0004510_myositis | 1.86319470 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.83255132 |
| 32 | MP0002405_respiratory_system_inflammati | 1.65851491 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.65824361 |
| 34 | MP0002398_abnormal_bone_marrow | 1.64373882 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.60079711 |
| 36 | MP0000716_abnormal_immune_system | 1.59621294 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.55279170 |
| 38 | MP0009278_abnormal_bone_marrow | 1.54503224 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.53591830 |
| 40 | MP0002006_tumorigenesis | 1.51369180 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.49255724 |
| 42 | MP0005360_urolithiasis | 1.47241711 |
| 43 | MP0008469_abnormal_protein_level | 1.46315024 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.44926557 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.44111733 |
| 46 | MP0003724_increased_susceptibility_to | 1.43567066 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.42321640 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.41869939 |
| 49 | MP0001873_stomach_inflammation | 1.39588945 |
| 50 | MP0004883_abnormal_blood_vessel | 1.38610655 |
| 51 | MP0004381_abnormal_hair_follicle | 1.36149207 |
| 52 | MP0002722_abnormal_immune_system | 1.35892208 |
| 53 | MP0002429_abnormal_blood_cell | 1.34727145 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.30136654 |
| 55 | MP0005310_abnormal_salivary_gland | 1.29864262 |
| 56 | MP0001853_heart_inflammation | 1.29813690 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.26941725 |
| 58 | MP0002139_abnormal_hepatobiliary_system | 1.25471599 |
| 59 | MP0000604_amyloidosis | 1.24501947 |
| 60 | MP0005365_abnormal_bile_salt | 1.23751273 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.23309452 |
| 62 | MP0003690_abnormal_glial_cell | 1.21923150 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.21635383 |
| 64 | MP0003252_abnormal_bile_duct | 1.21144658 |
| 65 | MP0005164_abnormal_response_to | 1.20882151 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.20593155 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.17902769 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.17829310 |
| 69 | MP0003329_amyloid_beta_deposits | 1.15502172 |
| 70 | MP0003448_altered_tumor_morphology | 1.15465927 |
| 71 | MP0000371_diluted_coat_color | 1.13936610 |
| 72 | MP0000609_abnormal_liver_physiology | 1.13804509 |
| 73 | MP0000015_abnormal_ear_pigmentation | 1.12343420 |
| 74 | MP0009764_decreased_sensitivity_to | 1.12317946 |
| 75 | MP0002998_abnormal_bone_remodeling | 1.11557214 |
| 76 | MP0003075_altered_response_to | 1.11077095 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.09740024 |
| 78 | MP0002933_joint_inflammation | 1.07845256 |
| 79 | MP0001958_emphysema | 1.06163876 |
| 80 | MP0002254_reproductive_system_inflammat | 1.05383237 |
| 81 | MP0009763_increased_sensitivity_to | 1.03803827 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 1.02037669 |
| 83 | MP0005076_abnormal_cell_differentiation | 1.01903556 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 1.01267190 |
| 85 | MP0001545_abnormal_hematopoietic_system | 1.01267190 |
| 86 | MP0000343_altered_response_to | 1.01228545 |
| 87 | MP0003045_fibrosis | 0.99945431 |
| 88 | MP0003091_abnormal_cell_migration | 0.98833599 |
| 89 | MP0001851_eye_inflammation | 0.97460183 |
| 90 | MP0010307_abnormal_tumor_latency | 0.95568726 |
| 91 | MP0010329_abnormal_lipoprotein_level | 0.94359326 |
| 92 | MP0004130_abnormal_muscle_cell | 0.91204824 |
| 93 | MP0000858_altered_metastatic_potential | 0.90960348 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 0.90131375 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.89225296 |
| 96 | MP0006054_spinal_hemorrhage | 0.89068261 |
| 97 | MP0000920_abnormal_myelination | 0.88249941 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.88015098 |
| 99 | MP0000249_abnormal_blood_vessel | 0.87689772 |
| 100 | MP0003866_abnormal_defecation | 0.86253527 |
| 101 | MP0005166_decreased_susceptibility_to | 0.85744860 |
| 102 | MP0003279_aneurysm | 0.85366471 |
| 103 | MP0003795_abnormal_bone_structure | 0.84357634 |
| 104 | MP0005023_abnormal_wound_healing | 0.81610584 |
| 105 | MP0005390_skeleton_phenotype | 0.81417469 |
| 106 | MP0002132_abnormal_respiratory_system | 0.81099750 |
| 107 | MP0005670_abnormal_white_adipose | 0.80705789 |
| 108 | MP0001915_intracranial_hemorrhage | 0.80479975 |
| 109 | MP0008004_abnormal_stomach_pH | 0.78325675 |
| 110 | MP0000598_abnormal_liver_morphology | 0.77558552 |
| 111 | MP0005083_abnormal_biliary_tract | 0.76524523 |
| 112 | MP0002928_abnormal_bile_duct | 0.75668108 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.72530568 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.71793796 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.71751423 |
| 116 | MP0010352_gastrointestinal_tract_polyps | 0.71617488 |
| 117 | MP0005085_abnormal_gallbladder_physiolo | 0.71369485 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.70907955 |
| 119 | MP0001849_ear_inflammation | 0.67795476 |
| 120 | MP0003806_abnormal_nucleotide_metabolis | 0.64904547 |
| 121 | MP0005409_darkened_coat_color | 0.63716555 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.61261490 |
| 123 | MP0002133_abnormal_respiratory_system | 0.57080429 |
| 124 | MP0005388_respiratory_system_phenotype | 0.57080429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.03958211 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.89532739 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.40540694 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.32968843 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.16878560 |
| 6 | Recurrent viral infections (HP:0004429) | 3.63435764 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.53761445 |
| 8 | Dysostosis multiplex (HP:0000943) | 3.41735523 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.41120443 |
| 10 | Recurrent skin infections (HP:0001581) | 3.28550483 |
| 11 | Glomerulonephritis (HP:0000099) | 3.24272319 |
| 12 | Periodontitis (HP:0000704) | 3.24236242 |
| 13 | Colitis (HP:0002583) | 3.22520279 |
| 14 | Cellulitis (HP:0100658) | 3.18867240 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.16476656 |
| 16 | Myocardial infarction (HP:0001658) | 3.15855300 |
| 17 | Myositis (HP:0100614) | 3.09689506 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 3.07848804 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.01768399 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.01768399 |
| 21 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.01639210 |
| 22 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.01639210 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.01639210 |
| 24 | Gingivitis (HP:0000230) | 3.01154595 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.00004617 |
| 26 | Complement deficiency (HP:0004431) | 2.94944653 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 2.90579508 |
| 28 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.87607278 |
| 29 | Pustule (HP:0200039) | 2.84426045 |
| 30 | Inflammation of the large intestine (HP:0002037) | 2.76320477 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.74408119 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.74408119 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.74408119 |
| 34 | Abnormality of complement system (HP:0005339) | 2.68685752 |
| 35 | Gingival bleeding (HP:0000225) | 2.67982813 |
| 36 | Gastrointestinal inflammation (HP:0004386) | 2.67845400 |
| 37 | Hematochezia (HP:0002573) | 2.65787228 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 2.63524678 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.62848669 |
| 40 | Amyloidosis (HP:0011034) | 2.57155253 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.55058850 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.52520419 |
| 43 | Loss of speech (HP:0002371) | 2.51939135 |
| 44 | Vasculitis (HP:0002633) | 2.51804727 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51326350 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51326350 |
| 47 | Orchitis (HP:0100796) | 2.50677103 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.49709527 |
| 49 | Chronic otitis media (HP:0000389) | 2.49013061 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.47093748 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.45429911 |
| 52 | Nephritis (HP:0000123) | 2.44192752 |
| 53 | Osteomyelitis (HP:0002754) | 2.43833841 |
| 54 | Arterial thrombosis (HP:0004420) | 2.40775773 |
| 55 | Abnormality of the fingertips (HP:0001211) | 2.39342644 |
| 56 | Meningitis (HP:0001287) | 2.38128954 |
| 57 | Hemoptysis (HP:0002105) | 2.36450543 |
| 58 | Neuronal loss in central nervous system (HP:0002529) | 2.36053112 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.34286430 |
| 60 | Purpura (HP:0000979) | 2.32874325 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.32551249 |
| 62 | Joint hemorrhage (HP:0005261) | 2.31807337 |
| 63 | Axonal loss (HP:0003447) | 2.30770082 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.30394725 |
| 65 | Mutism (HP:0002300) | 2.28614290 |
| 66 | Neurofibrillary tangles (HP:0002185) | 2.28237348 |
| 67 | Chest pain (HP:0100749) | 2.26681606 |
| 68 | Leukocytosis (HP:0001974) | 2.23224499 |
| 69 | Abnormal platelet function (HP:0011869) | 2.21356949 |
| 70 | Impaired platelet aggregation (HP:0003540) | 2.21356949 |
| 71 | Epistaxis (HP:0000421) | 2.21233208 |
| 72 | Mitral stenosis (HP:0001718) | 2.19324785 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.18468905 |
| 74 | Obstructive lung disease (HP:0006536) | 2.17762784 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17762784 |
| 76 | Retrobulbar optic neuritis (HP:0100654) | 2.17233049 |
| 77 | Optic neuritis (HP:0100653) | 2.17233049 |
| 78 | IgM deficiency (HP:0002850) | 2.15278303 |
| 79 | Global brain atrophy (HP:0002283) | 2.12499044 |
| 80 | Thoracic kyphosis (HP:0002942) | 2.12120498 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.09907145 |
| 82 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08293620 |
| 83 | Osteolytic defects of the hand bones (HP:0009699) | 2.08293620 |
| 84 | Increased serum ferritin (HP:0003281) | 2.07976699 |
| 85 | Encephalitis (HP:0002383) | 2.07781376 |
| 86 | Apathy (HP:0000741) | 2.06602096 |
| 87 | T lymphocytopenia (HP:0005403) | 2.04801636 |
| 88 | Diminished motivation (HP:0000745) | 2.04661523 |
| 89 | Urticaria (HP:0001025) | 2.03795478 |
| 90 | Pathologic fracture (HP:0002756) | 2.01530578 |
| 91 | Recurrent bronchitis (HP:0002837) | 2.01004696 |
| 92 | Thyroiditis (HP:0100646) | 2.00989719 |
| 93 | Panhypogammaglobulinemia (HP:0003139) | 2.00808448 |
| 94 | Asymmetric septal hypertrophy (HP:0001670) | 2.00661302 |
| 95 | Abnormality of T cell number (HP:0011839) | 2.00328169 |
| 96 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.00167023 |
| 97 | Spondylolisthesis (HP:0003302) | 1.99138502 |
| 98 | Malnutrition (HP:0004395) | 1.98953798 |
| 99 | Peritonitis (HP:0002586) | 1.98733047 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98241622 |
| 101 | Premature loss of primary teeth (HP:0006323) | 1.96122653 |
| 102 | Abnormal platelet volume (HP:0011876) | 1.96000297 |
| 103 | Menorrhagia (HP:0000132) | 1.94450189 |
| 104 | Disinhibition (HP:0000734) | 1.94254213 |
| 105 | Gastrointestinal stroma tumor (HP:0100723) | 1.93282826 |
| 106 | Chronic diarrhea (HP:0002028) | 1.92870229 |
| 107 | Petechiae (HP:0000967) | 1.92335942 |
| 108 | Deep venous thrombosis (HP:0002625) | 1.91904380 |
| 109 | Cerebral inclusion bodies (HP:0100314) | 1.90272560 |
| 110 | Pulmonary infiltrates (HP:0002113) | 1.90270258 |
| 111 | Prostate neoplasm (HP:0100787) | 1.90121039 |
| 112 | Thick nail (HP:0001805) | 1.89415971 |
| 113 | Absent frontal sinuses (HP:0002688) | 1.89189934 |
| 114 | Abnormality of the thoracic spine (HP:0100711) | 1.86510216 |
| 115 | Emphysema (HP:0002097) | 1.86478715 |
| 116 | Lymphopenia (HP:0001888) | 1.86342349 |
| 117 | Slow saccadic eye movements (HP:0000514) | 1.85888652 |
| 118 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.85221822 |
| 119 | Aortic aneurysm (HP:0004942) | 1.84845866 |
| 120 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84828889 |
| 121 | Progressive neurologic deterioration (HP:0002344) | 1.81860108 |
| 122 | Pulmonary embolism (HP:0002204) | 1.81816288 |
| 123 | Stomatitis (HP:0010280) | 1.81404775 |
| 124 | Eosinophilia (HP:0001880) | 1.81073081 |
| 125 | Restrictive lung disease (HP:0002091) | 1.80775381 |
| 126 | Sepsis (HP:0100806) | 1.80558053 |
| 127 | Increased IgE level (HP:0003212) | 1.80252181 |
| 128 | Albinism (HP:0001022) | 1.79327442 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.76477105 |
| 130 | Abnormality of the peritoneum (HP:0002585) | 1.75254409 |
| 131 | Vertebral compression fractures (HP:0002953) | 1.75220216 |
| 132 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73701837 |
| 133 | Hypergammaglobulinemia (HP:0010702) | 1.73417953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.85232522 |
| 2 | BLK | 3.19257801 |
| 3 | TYK2 | 3.05229268 |
| 4 | ERN1 | 2.65199843 |
| 5 | PRPF4B | 2.58762852 |
| 6 | MAP3K14 | 2.55813292 |
| 7 | JAK1 | 2.33054316 |
| 8 | TGFBR2 | 2.25389951 |
| 9 | IRAK4 | 2.24938853 |
| 10 | RIPK4 | 2.23569129 |
| 11 | TAOK3 | 2.18068160 |
| 12 | TBK1 | 2.17915273 |
| 13 | KIT | 2.17380767 |
| 14 | CSF1R | 2.06099743 |
| 15 | TRIB3 | 2.05527736 |
| 16 | JAK3 | 2.04621948 |
| 17 | CAMK1D | 2.00172751 |
| 18 | IRAK3 | 1.94718716 |
| 19 | CDK12 | 1.90025032 |
| 20 | ZAP70 | 1.82284712 |
| 21 | FGFR4 | 1.77478759 |
| 22 | MAP3K13 | 1.75765106 |
| 23 | CSK | 1.71708607 |
| 24 | STK10 | 1.63519123 |
| 25 | IKBKE | 1.62428162 |
| 26 | MAP3K10 | 1.59557755 |
| 27 | EPHB1 | 1.59400949 |
| 28 | MAP3K3 | 1.58726382 |
| 29 | SYK | 1.52857046 |
| 30 | TXK | 1.52196252 |
| 31 | ITK | 1.46219509 |
| 32 | HCK | 1.42276445 |
| 33 | IKBKB | 1.42192575 |
| 34 | CAMK1G | 1.41358862 |
| 35 | PTK6 | 1.34124678 |
| 36 | KSR2 | 1.32925336 |
| 37 | TTN | 1.32812631 |
| 38 | BTK | 1.29512399 |
| 39 | TEC | 1.27775729 |
| 40 | PKN2 | 1.27436218 |
| 41 | SIK1 | 1.25569926 |
| 42 | TAOK1 | 1.23549326 |
| 43 | FGFR3 | 1.19929578 |
| 44 | CDC42BPA | 1.19142216 |
| 45 | GRK6 | 1.17416082 |
| 46 | CHUK | 1.15106206 |
| 47 | LCK | 1.14902151 |
| 48 | GRK7 | 1.14603335 |
| 49 | EEF2K | 1.11581418 |
| 50 | JAK2 | 1.11198035 |
| 51 | MAP3K1 | 1.11020366 |
| 52 | FES | 1.09564501 |
| 53 | TNK2 | 1.09319360 |
| 54 | MARK2 | 1.07968892 |
| 55 | MAP2K3 | 1.06750957 |
| 56 | RIPK1 | 1.06654570 |
| 57 | LYN | 1.05206879 |
| 58 | MATK | 1.05174889 |
| 59 | CLK1 | 1.02468351 |
| 60 | MOS | 0.98029215 |
| 61 | SIK3 | 0.95453074 |
| 62 | SCYL2 | 0.93171985 |
| 63 | SIK2 | 0.92332300 |
| 64 | RPS6KA4 | 0.92088138 |
| 65 | TRPM7 | 0.90257845 |
| 66 | LRRK2 | 0.89882226 |
| 67 | MAP3K2 | 0.89805579 |
| 68 | TAOK2 | 0.87702153 |
| 69 | PDK2 | 0.85168282 |
| 70 | MAP3K11 | 0.83542457 |
| 71 | NEK9 | 0.83432546 |
| 72 | CAMKK2 | 0.82264248 |
| 73 | BMPR2 | 0.80210715 |
| 74 | PIM1 | 0.78637515 |
| 75 | MARK3 | 0.77447499 |
| 76 | SGK3 | 0.76462523 |
| 77 | PDGFRB | 0.68073380 |
| 78 | CDK6 | 0.67631472 |
| 79 | STK4 | 0.67536268 |
| 80 | FLT3 | 0.67406382 |
| 81 | IRAK2 | 0.66499639 |
| 82 | INSRR | 0.66425238 |
| 83 | CAMKK1 | 0.66175632 |
| 84 | RAF1 | 0.65938735 |
| 85 | KSR1 | 0.64724135 |
| 86 | PRKD2 | 0.64145883 |
| 87 | FGR | 0.63631727 |
| 88 | PDK1 | 0.63448881 |
| 89 | BRD4 | 0.60843740 |
| 90 | IRAK1 | 0.59715143 |
| 91 | EGFR | 0.59379469 |
| 92 | PRKCH | 0.58650221 |
| 93 | RPS6KA2 | 0.57745064 |
| 94 | NUAK1 | 0.57436486 |
| 95 | MAP3K7 | 0.56662482 |
| 96 | ICK | 0.55137273 |
| 97 | PRKCQ | 0.54484988 |
| 98 | RPS6KC1 | 0.54138585 |
| 99 | RPS6KL1 | 0.54138585 |
| 100 | DDR2 | 0.53233760 |
| 101 | PDPK1 | 0.52277396 |
| 102 | HIPK2 | 0.51634589 |
| 103 | EPHA3 | 0.51037020 |
| 104 | TESK2 | 0.50862940 |
| 105 | ARAF | 0.50646512 |
| 106 | MAPK11 | 0.50631217 |
| 107 | PRKAA2 | 0.50139380 |
| 108 | TIE1 | 0.46741114 |
| 109 | ABL1 | 0.45957958 |
| 110 | MTOR | 0.45194038 |
| 111 | SMG1 | 0.45145708 |
| 112 | FYN | 0.45120435 |
| 113 | IGF1R | 0.44583578 |
| 114 | BMX | 0.44504255 |
| 115 | RET | 0.44105602 |
| 116 | STK3 | 0.42681698 |
| 117 | MAP3K5 | 0.42644636 |
| 118 | MAPK12 | 0.41582644 |
| 119 | NEK6 | 0.38514823 |
| 120 | PIK3CG | 0.37089437 |
| 121 | CAMK4 | 0.36969462 |
| 122 | MAPKAPK2 | 0.35848145 |
| 123 | DMPK | 0.34362411 |
| 124 | MAPK7 | 0.34204692 |
| 125 | MELK | 0.34195837 |
| 126 | PAK4 | 0.34005833 |
| 127 | MAP3K6 | 0.33067717 |
| 128 | CDK9 | 0.32491929 |
| 129 | NLK | 0.32000333 |
| 130 | PRKCD | 0.31787549 |
| 131 | MAP3K8 | 0.31710314 |
| 132 | RPS6KA6 | 0.31649072 |
| 133 | YES1 | 0.30861730 |
| 134 | INSR | 0.30192787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.58050047 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66786460 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.53554180 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.43958047 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41301410 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.17942529 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09172229 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.05532755 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.89504991 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.86738117 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.84935935 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81687706 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78757467 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74502884 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72384476 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70513725 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.69944860 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58446585 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56731965 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56080339 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.54429892 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49543542 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47115965 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46845694 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.46422831 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.45841842 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45653661 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.42137763 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.37152229 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35955137 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.35470606 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32305203 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.24038413 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22500069 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18887669 |
| 36 | Lysine degradation_Homo sapiens_hsa00310 | 1.18627640 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18437033 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17811955 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12449910 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12262167 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11280956 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.07978070 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07061199 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06753347 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06582155 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01267168 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.00812125 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.00679845 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.98872623 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.97662244 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97414531 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96566784 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95225420 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92683234 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89403838 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.89373169 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89287739 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.89078262 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87827889 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.87755558 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84293725 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82892380 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82618067 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79410964 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79330677 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78546405 |
| 67 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76834751 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.76802692 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76184067 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75803968 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.75003849 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74244122 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71828513 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68911136 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67732348 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.67577137 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67002823 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64843790 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64572786 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63429521 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62803472 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61932546 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61317415 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61112163 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60657695 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59917510 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59043927 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57687617 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56144218 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55120389 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54526909 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54013647 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53951699 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52679604 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52020151 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.51673483 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51583578 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51346593 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49600558 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.48408074 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47992051 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47766538 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46496218 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45075461 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.44918299 |
| 106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44459299 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43613793 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43349781 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42547816 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40786885 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40397953 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.39278304 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39193768 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37967126 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36606916 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36185877 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.35245402 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.35044479 |
| 119 | Adherens junction_Homo sapiens_hsa04520 | 0.34817754 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32291921 |
| 121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31906752 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31195459 |

